Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Eriksson

Showing results (371-380 of 377) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 377 results.
Bioorganic & Medicinal Chemistry Letters|September 4, 2012
Phenethyl nicotinamides, a novel class of Na(V)1.7 channel blockers: structure and activity relationshipInger Kers, Istvan Macsari, Gabor Csjernyik, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinN D Yeomans, A I Lanas, N J Talley, et al.
Neuroendocrinology|April 20, 2005
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)U Plöckinger, G Rindi, R Arnold, et al.
Journal of Medicinal Chemistry|July 10, 2012
3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain modelsIstvan Macsari, Yevgeni Besidski, Gabor Csjernyik, et al.
Human Molecular Genetics|June 29, 2007
A stop codon mutation in SCN9A causes lack of pain sensationSultan Ahmad, Leif Dahllund, Anders B Eriksson, et al.
ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.
The Review of Scientific Instruments|September 24, 2024
Learning from each other: Cross-cutting diagnostic development activities between magnetic and inertial confinement fusion (invited)M Gatu Johnson, D Schlossberg, B Appelbe, et al.
Pageof 38

Showing results (371-380 of 377) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 377 results.
Bioorganic & Medicinal Chemistry Letters|September 4, 2012
Phenethyl nicotinamides, a novel class of Na(V)1.7 channel blockers: structure and activity relationshipInger Kers, Istvan Macsari, Gabor Csjernyik, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinN D Yeomans, A I Lanas, N J Talley, et al.
Neuroendocrinology|April 20, 2005
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)U Plöckinger, G Rindi, R Arnold, et al.
Journal of Medicinal Chemistry|July 10, 2012
3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain modelsIstvan Macsari, Yevgeni Besidski, Gabor Csjernyik, et al.
Human Molecular Genetics|June 29, 2007
A stop codon mutation in SCN9A causes lack of pain sensationSultan Ahmad, Leif Dahllund, Anders B Eriksson, et al.
ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.
The Review of Scientific Instruments|September 24, 2024
Learning from each other: Cross-cutting diagnostic development activities between magnetic and inertial confinement fusion (invited)M Gatu Johnson, D Schlossberg, B Appelbe, et al.
Pageof 38